Quipt Home Medical Announces Supply Contract with Cardinal Health Further Expanding Continuum of Care

Quipt Home Medical Corp | July 26, 2022 | Read time : 34:22 min

Quipt Home

Quipt Home Medical Corp. a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce the execution of a contract with Cardinal Health at-Home, a business unit of Cardinal Health, Inc. wherein Quipt has agreed to offer to sell, and Cardinal has agreed to supply and distribute, disposable medical supplies nationwide. Headquartered in Dublin, Ohio, Cardinal Health, Inc. is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities.  

The execution of this contract with Cardinal Health for the supply of disposable medical supplies is an important milestone for Quipt, and we are thrilled to form this alliance during a period of significant growth. Cardinal will service our entire operating footprint, consisting of 94 locations across the country aimed at increasing distribution channels while decreasing costs. Furthermore, this contract will provide us the ability to expand our continuum of care, produce meaningful cross selling opportunities and allow us to further leverage the national insurance contract recently announced. This contract with Cardinal will also assist us in expanding our presence in the states we serve giving us additional verticals to go after. Additionally, any new acquisitions, will benefit from being able to immediately leverage the contract at new locations across the country, providing further synergies with the expectation this contract will give us stronger buying power for disposable medical supplies. The contract with Cardinal, recent new national insurance contract, and deep acquisition pipeline have us extremely excited about the remainder of 2022 and beyond.” 

 Greg Crawford, Chairman and CEO of Quipt

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Cardinal Health at-Home provides Home Medical Equipment and Home Health and Hospice teams with comprehensive solutions to better support their patients in the home.


Nothing comes close to the CT4-LX-HC thermal desktop Healthcare printer. Seamlessly combining intelligence, functionality and performance. Standard features include clinical-ready antimicrobial plastic casing


Nothing comes close to the CT4-LX-HC thermal desktop Healthcare printer. Seamlessly combining intelligence, functionality and performance. Standard features include clinical-ready antimicrobial plastic casing

Related News


Cardinal Health and Signify Health Improve Treatment with In-Home Services

Signify Health | March 08, 2023

Cardinal Health recently announced a partnership with Signify Health to provide clinical and medication management services in-home through its OutcomesTM business. This partnership will support the prescription-to-pharmacy-to-home treatment journey for more than 2.3 million members across the US by reducing costs and eliminating care gaps. Numerous members do not follow their prescribed medications, according to studies. By combining Signify Health's mobile network of 11,000+ credentialed clinicians with Outcomes' industry-leading OutcomesOneTM clinical care platform and omnichannel network of payers and pharmacies, this collaboration will assist in solving medication management challenges for members of the health plan. It will achieve this by providing coordinated care from Signify Health clinicians, who will also perform evaluations of those members at-home. Signify Health can use the OutcomesOneTM platform to determine and address patients' medication therapy management requirements based on the information gathered during in-home evaluations. The collaboration will initially focus on interventions advised for Medicare Advantage members of mutual clients and may expand to include additional services, like clinical interventions and population health programs. David Pierre, COO of Signify Health, stated, "From our experience conducting medication reviews in thousands of homes each day, we understand the importance of making medication management more convenient, accessible and connected to daily life." He added, "We look forward to joining forces with Outcomes to bring this vital service to improve medication safety and adherence and drive more value for the people we are privileged to serve." (Source – Cision PR Newswire) About Signify Health Signify Health is a premier healthcare platform that empowers healthcare organizations to create and power value-based payment programs. Its mission is to build trusted relationships with patients and providers to make people healthier. The company achieves this mission by leveraging advanced analytics, technology, and nationwide healthcare provider networks. As a result, its platform helps reduce costs and eliminate gaps in care while supporting patients' treatment journey from prescription to the pharmacy to home.

Read More


Osigu Announces an Agreement to Acquire Servinte, The Largest Electronic Health Record (EHR) and Healthcare Software Provider in Colombia

Prnewswire | April 03, 2023

Osigu, Inc., announced that an agreement has been reached with Carvajal Group for the acquisition of Servinte, one of their subsidiaries, and the leading EHR and Healthcare Administration Software provider in Colombia. Osigu plans to enhance Servinte's capabilities by integrating top-of-the-line technologies and adding transactional capabilities. With over 30 years of providing technology solutions to the healthcare industry in Colombia, Servinte has a strong reputation in the market, working with over 50 Hospital Systems supporting clinical, administrative, and financial operations. Osigu plans to integrate into a single technology platform, offering comprehensive and real-time revenue cycle, claims processing, and healthcare payments in the Colombian market. "We are excited to be part of this transaction with Osigu. We believe this combination creates value and is a turning point for the healthcare market in Colombia," stated Pedro Felipe Carvajal, CEO of Carvajal Group. "We are impressed with Osigu's technology, team, and vision, and we believe they are the right partner to take Servinte to the next level." "We are thrilled about this acquisition and the opportunity to enter the Colombian market," said Fernando Botrán, CEO and founder of Osigu. "There is clear potential for growth and collaboration, and it was a natural fit for both companies and teams. We are committed to providing the best solutions to our clients and stakeholders." Miami-based Osigu was founded in 2015 with the mission of making the healthcare experience better for everyone through innovative solutions. Once the acquisition process is completed, the company will have more than 65 enterprise healthcare clients and partnerships in Mexico, the Dominican Republic, Central America, Spain, and Colombia. Osigu has undergone swift expansion, resulting in long-term contracts and the consolidation of a robust platform that has handled over 2 million transactions. In 2022, the company experienced a 330% increase in its annual recurring revenue on a year-over-year basis, as compared to 2021. Among its board members are strategic investors such as Jose Vargas, co-founder of healthcare.com, a leading digital health insurance company in the US, and Bobby Aitkenhead, Managing Director of IDC Ventures, a venture capital fund that focuses on companies in the fintech, platform, and marketplace verticals in EU, US, and LATAM. "With a TAM of USD $12 Billion, and processing over 650 Million claims each year, the Colombian healthcare market becomes a huge opportunity to deliver on our vision of leveraging the latest technologies and innovations to deliver affordable, accessible, and personalized healthcare to patients," added Botrán, who expects more M&A opportunities to come as part of their growth strategy. About Osigu Osigu is disrupting the healthcare and insurance ecosystem by digitalizing and automating the claims process and payments between payers and health providers in LATAM. Through a unique, state of the art, SaaS platform, payers, health providers, and patients interact in a simple, reliable and secure manner. Osigu provides solutions for everyone in the healthcare delivery ecosystem: efficiency and fraud prevention for payers, liquidity for health providers, and a better customer experience for patients.

Read More


Laborie Launches alpHaONE, an Innovative GERD Diagnostic System

prnewswire | April 04, 2023

Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. announced the launch of the alpHaONE system that is specifically designed to diagnose gastroesophageal reflux disease and offers up to 96 hours of monitoring data. GERD is a chronic medical condition caused by the flow of contents from the stomach upwards into the esophagus resulting in both symptoms and complications. It is estimated that 20% of the US population suffers from GERD with the most common symptoms being heartburn and regurgitation1. With an increasing number of options for GERD diagnosis, patients and healthcare providers face a challenge in choosing the best solution for a clear diagnosis. alpHaONE offers a unique solution with its ergonomic and compact design, enlarged and easy-to-press buttons, and fail-safe capsule delivery system that protects the patient's esophagus. "alpHaONE is a patient-centric system that allows for comfortable monitoring and accurate, reliable data, fulfilling the needs of both patients and healthcare providers to diagnosis GERD," said Rhett Klein, Vice President of Sales and Marketing for Laborie's GI Business Unit. "Our primary objective has always been to provide solutions that elevate patient outcomes and enhance their overall experience and we look forward to launching this product." The comprehensive software application incorporated in the alpHaONE system consists of a Virtual Instruction Program, which allows for effortless navigation. In addition, user-customizable symptom buttons and automatic pH data analysis ensure a seamless user experience. Laborie will showcase alpHaONE at the Digestive Disease Week (DDW) event in Chicago, Illinois on May 6-9, 2023. About Laborie Medical Technologies Laborie is a global medical technology company focused on Urology, Urogynecology, Gastroenterology, Obstetrics, Gynecology & Neonatal Health headquartered in Portsmouth, New Hampshire. We manufacture and deliver high-quality, high-impact diagnostic and therapeutic products that help clinicians and hospitals preserve and restore patient dignity. Clinicians and hospitals look to us as the market-leading experts in our business segments, and we support our products with a world-class Clinical Education & Information program.

Read More